Disease-Free Survival

Disease-Free Survival (DFS) is the length of time after treatment during which a patient remains alive with no detectable signs of their cancer returning. It is used in clinical trials to compare how well different therapies prevent recurrence. DFS is distinct from Overall Survival, which measures total time alive regardless of whether the cancer has come back.

Origin

The term emerged from oncology clinical trial methodology in the mid-20th century as researchers sought endpoints beyond simple mortality. It was formalized in the 1970s and 1980s as cooperative cancer trial groups standardized outcome measures, and it has been refined by regulatory bodies including the FDA and EORTC for use in trial design and drug approval.

Significance in Asbestos Context

For mesothelioma and asbestos-related lung cancer patients, DFS is one of the key numbers used to judge whether a surgery, chemotherapy regimen, or immunotherapy is actually working. Because mesothelioma frequently recurs even after aggressive treatment, DFS figures from clinical trials help patients and their oncologists set realistic expectations and compare options like pleurectomy/decortication versus extrapleural pneumonectomy, or first-line chemotherapy versus immunotherapy combinations. In legal proceedings, DFS data also informs life-expectancy testimony and the calculation of future medical costs, lost earnings, and damages. Defendants may cite DFS statistics to argue prognosis, while plaintiffs' experts use the same data to document the burden of recurrence monitoring and re-treatment.

Example Sentence

Her oncologist explained that the new immunotherapy combination had improved median disease-free survival in the trial, which was an important factor in deciding whether to pursue it after surgery.

Related Terms

Overall Survival, Progression-Free Survival, Recurrence, Median Survival, Prognosis, Clinical Trial Endpoint

Notes

• Ask your oncology team what DFS numbers exist for your specific treatment plan and how they compare to other options, and request the actual trial citations so you or your family can review them.
• Keep copies of every imaging report (CT, PET, MRI) and pathology result; these establish the date of any recurrence and are essential for both medical decision-making and damages calculations in a legal claim.
• If you are enrolled in or considering a clinical trial, ask whether DFS or Progression-Free Survival is the primary endpoint, because the two are measured differently and affect how 'success' is defined.
• Share DFS expectations with your legal team early; life-expectancy and future-care projections in your case will often be built around survival statistics specific to your disease stage and treatment.